Earnings

WAVE Life Sciences Q2 EPS $(0.34) Misses $(0.31) Estimate, Sales $2.272M Miss $7.050M Estimate

Jul 30, 2026 · 07:31 AM ET· updated 2h ago

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 9.68 percent decrease over losses of $(0.31) per share

Why It Matters

WAVE Life Sciences lost more money per share than experts predicted, and made way less sales than expected. When a company misses both numbers, it means the business isn't growing as fast as people hoped.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

WVE5.73

-0.08 (-1.36%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.